CBS News
@CBSNews·7M subscribers·153.5K videos
Neuropsychiatrist on "incredibly rare" condition linked to Johnson & Johnson COVID-19 vaccine
Posted
July 13, 2021
Views
28,576
Likes
289
Comments
518
Engagement
July 13, 2021
28,576
289
518
2.82%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:31Now PlayingThe FDA is monitoring the possibility that the Johnson and Johnson's COVID-19 vaccine could be linked to an increased risk of developing Guillain-Barré Syndrome. Neuropsychiatrist Brittany LeMonda, PhD, spoke with Tanya Rivero on CBSN about what this condition is, the signs to look out for, and her advice for patients who are concerned about their vaccine.
CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the Paramount+ subscription service.
Subscribe to the CBS News YouTube channel
Watch CBSN live
Download the CBS News app
Follow CBS News on Instagram
Like CBS News on Facebook
Follow CBS News on Twitter
Subscribe to our newsletters
Try Paramount+ free
For video licensing inquiries, contact: licensing@veritone.com
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
